Designed to deliver microscopic medical particles (called tin-117m), Synovetin OA treats inflammation inside the joint, eliminating the harmful cells that cause arthritis to develop and get worse over time. It’s similar to the medical radiotherapy that is routinely used to safely and effectively treat numerous medical conditions in people.
Other dog arthritis treatments work to mask pain symptoms but can’t address the cause of the disease itself the way Synovetin OA can. And, because Synovetin OA works only inside the arthritic joint, it does not spread throughout the body like other treatments do, which can cause side effects.
It’s a simple, safe, fast arthritis injection, after which your dog can go home with you the same day. And there’s no need for the inconvenient restraint that comes with invasive procedures.
No systemic
side effects4
Just 1 fast, simple
minimally-invasive treatment
Up to 1 full year
of pain relief2,3
The active ingredient in Synovetin OA is only present in the body for a few weeks but the effect on inflammation and the resulting joint pain is very long-lasting—up to 1 full year, depending on the severity of arthritis. Plus, extensive safety studies and real-world use of Synovetin OA showed it does not cause systemic adverse effects and is safe for your dog, other pets, and your family.
Just 1 simple treatment has been proven to relieve OA pain for up to 1 full year.2,3
Studied in canine elbows, Synovetin OA is given by authorized veterinarians. Temporary discomfort in treated joints may occur. Talk to a treating veterinarian near you for more information including what to expect following treatment and visit activedognow.com.
1. Romer FW, Guermazi A, Felson DT, et al. Ann Rheum Dis. 2011;70(10):1804-1809. doi: 10.1136/ard.2011.150243. 2. Sellam J, Berenbaum F. Nat Rev Rheumatol. 2010; 6:625-635. https://doi.org/10.1038/nrrheum.2010.159 PMID: 20924410. 3. Scanzello CR, Umoh E, Pessler F, et al. Osteoarthritis Cartilage. 2009; 17: 1040-1048. https://doi.org/10.1016/j.joca.2009.02.011 PMID: 192892341. 4. Aulakh KS, Lopez MJ, Hudson C, et al. Vet Med (Auckl). 2021. Jun 4;12:117-128. doi: 10.2147/VMRR.S295309. PMID: 34113552; PMCID: PMC8187093. 5. Donecker J, Fabiani M, Gaschen L, Aulakh KS. PLoS One. 2021. Jul 19;16(7):e0254613. doi: 10.1371/journal.pone.0254613. PMID: 34280212; PMCID: PMC8289027. 6. Donecker J, Lattimer JC, Gaschen L, Aulakh KS. Vet Med (Auckl). 2021. Dec 17;12:325-335. doi: 10.2147/VMRR.S345144. PMID: 34950571; PMCID: PMC8691448. 7. Lattimer JC, Selting KA, Lunceford JM, et al. Vet Radiol Ultrasound. 2019. Sep;60(5):567-574. doi: 10.1111/vru.12757. Epub 2019 Jun 2. PMID: 31155782. 8. Doerr C, Bendele A, Simon J, et al. Poster presented at the Society of Nuclear Medicine & Molecular Imaging Annual Conference. San Diego, CA. 2016. 9. Data on File. Pathology Report. Bolder BioPATH, Inc.; Boulder, CO.
